Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
HeartVista to Expand Beyond Heart MRIs and Changes Name to Vista.ai to Reflect Wider Focus
HeartVista, a pioneer and leader in automated MRI solutions, has announced that it has changed […]
NHS Fast Tracks Life-Extending Prostate Cancer Drug to Patients
Around 9,000 men with one of the most advanced forms of prostate cancer will be […]
Brainomix Announces New Partnership with Pixyl to Expand its Offering with Multiple Sclerosis Solution
Brainomix, an AI-powered medtech solutions company, has announced a new partnership with Pixyl, an award-winning, […]
Chemotherapy May be Completed within 8 days with Two Doses of Polytaxel, an Innovative Anticancer Drug from South Korea's Biotech Firm
An innovative anticancer therapy that may complete chemotherapy with two doses of an anticancer drug […]
XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development
XtalPi have announced that they are embarking on a strategic collaboration with CK Life Sciences, […]
Montana Psychiatry & Brain Health Center Joins Turnwell Mental Health Network in New Growth Partnership
Turnwell Mental Health Network and Montana Psychiatry & Brain Health Center (“Montana Psychiatry”), a leading provider […]
InnovAge Announces Release of CMS Sanction in Sacramento Center
InnovAge, a market-leading healthcare delivery platform for high-cost, dual-eligible seniors, announced today that the Centers […]
Amedisys Names Scott Ginn Acting Chief Operating Officer
Amedisys, a leading provider of home health, hospice, personal care and high-acuity care, names Scott […]
HHS Awards ICF Over $45 Million in Digital Modernization Contracts
The U.S. Department of Health and Human Services‘ (HHS) Centers for Medicare & Medicaid Services […]
Health Net Providing Special Assistance to Members Affected by Wildfires and Flash Flooding
In response to Gov. Gavin Newsom‘s declared state of emergencies in Alpine, El Dorado, Inyo, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more